These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3830784)

  • 21. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3616-22. PubMed ID: 11709353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro comparison of the antibacterial activity of 1st, 2d, and 3d generation cephalosporins].
    Messmer JC; Lecaillon-Thibon E; Bon F; Soler H
    Sem Hop; 1983 Sep; 59(34):2389-92. PubMed ID: 6314522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial and antioxidant activities in Sideritis italica (Miller) Greuter et Burdet essential oils.
    Basile A; Senatore F; Gargano R; Sorbo S; Del Pezzo M; Lavitola A; Ritieni A; Bruno M; Spatuzzi D; Rigano D; Vuotto ML
    J Ethnopharmacol; 2006 Sep; 107(2):240-8. PubMed ID: 16690235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria.
    Shin SY; Bajpai VK; Kim HR; Kang SC
    Int J Food Microbiol; 2007 Jan; 113(2):233-6. PubMed ID: 16860896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative activity against Enterobacteriaceae and gram-positive bacteria.
    Gialdroni Grassi G; Mangiarotti P
    Chemioterapia; 1987 Jun; 6(2 Suppl):62-4. PubMed ID: 3509509
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative characterization of the sensitivity of regional strains of various microorganisms to cefuroxime and other antibiotics].
    Veselov AIa; Osokina OV
    Antibiot Khimioter; 1996; 41(10):32-4. PubMed ID: 9027292
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and biological activity of quaternary ammoniopropenylcephalosporins with hydroxylated alicyclic or aliphatic amines.
    Lee JY; Lee YS; Suk DW; Woo ER; Chung BY; Park H
    J Antibiot (Tokyo); 1996 Dec; 49(12):1286-9. PubMed ID: 9031678
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and antibacterial activities of new 3-phenoxymethylcephalosporins.
    Koyama K; Saito S; Kojima K
    J Antibiot (Tokyo); 1992 Apr; 45(4):535-41. PubMed ID: 1592685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cephalosporins: a pharmacological update.
    Novelli A; Conti S; Cassetta MI; Fallani S
    Clin Microbiol Infect; 2000; 6 Suppl 3():50-2. PubMed ID: 11449650
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and antibacterial activities of novel C(3)-aminopyrimidinyl substituted cephalosporins.
    Lee CS; Oh SH; Ryu EJ; Kim MY; Paek KS
    J Antibiot (Tokyo); 2000 Nov; 53(11):1305-9. PubMed ID: 11213293
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter to the editors regarding the scientific paper by González, Moreno, Fumuso, et al.
    Martinez MN; Whittem T
    J Vet Pharmacol Ther; 2010 Oct; 33(5):416; author reply 416-7. PubMed ID: 20840383
    [No Abstract]   [Full Text] [Related]  

  • 36. Cefpirome: epidemiological survey in intensive care units and hematological units in The Netherlands. The Dutch Study Group.
    Hoogkamp-Korstanje JA; Verduyn Lunel F; Meis JF
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):489-91. PubMed ID: 9635243
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cefepime--a fourth generation cephalosporin antibiotic].
    Iakovlev SV
    Antibiot Khimioter; 1999; 44(7):32-7. PubMed ID: 10494381
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics.
    Novelli A; Fallani S; Cassetta MI; Conti S
    Int J Antimicrob Agents; 2000 Dec; 16(4):501-5. PubMed ID: 11118868
    [No Abstract]   [Full Text] [Related]  

  • 39. New cephalosporin antibiotics with 3-triazolylpyridiniummethyl substituents.
    Chang KY; Kwon SH; Nam G; Seo JH; Kim SH; Choi KI; Kim JH; Ha DC
    J Antibiot (Tokyo); 2001 May; 54(5):460-2. PubMed ID: 11480891
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and activity of cephalosporins containing an oxyiminomethylene functionality in the ortho-position of a phenyl- or phenoxyacetic acid C-7 side chain substituent.
    Albanese D; Landini D; Leone M; Penso M; Zenoni M
    Farmaco; 1998; 53(10-11):709-17. PubMed ID: 10205858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.